This is always a clinical decision, but some patterns have emerged in the way providers describe their prescribing preferences: Tirzepatide tends to be preferred for patients seeking maximum weight loss, patients with type 2 diabetes (where the dual mechanism helps glycemic control), and patients who have not responded adequately to semaglutide
GLP-1 medications can alter levels of various hormones including insulin, leptin, and adipokines, all of which communicate nutritional status to the reproductive system
Patients who stop the medication gain back on average two thirds of the weight they had lost
| Read More $76.00 Semaglutide GLP-1 receptor agonist 5 lyophilised vials 2 mg (total 10 mg) Research focus: appetite suppression, delayed gastric emptying, improved insulin sensitivity and rapid fat-loss
Keep detailed logs that your healthcare provider can review at follow-up appointments